TABLE 1.

Demographics of survey participants

Attribute	N (%)
Status
Attending physician	148 (86.5%)
Nurse practitioner/physician assistant/mid‐level provider	10 (5.8%)
Trainee (student, resident, fellow)	13 (7.6%)
Specialty
Thrombosis	75 (43.9%)
Other	96 (56.1%)
Setting
Academic	144 (84.2%)
Nonacademic	27 (15.8%)
Percent of clinical time is outpatient care
<50	34 (19.9%)
50–79	71 (41.5%)
≥80	65 (38.0%)
Years in practice
≤10	86 (50.3%)
11–25	69 (40.4%)
>25	16 (9.4%)
Number of patients where you are involved in DOAC prescriptions
<50	16 (9.4%)
51–250	51 (29.8%)
>250	42 (24.6%)
Institutional protocol to consider DOAC dose adjustment in place
Yes	14 (8.2%)
No	93 (54.4%)
Don't know	61 (35.7%)
Country
North America	116 (67.8%)
Europe	31 (18.1%)
Other	24 (14.0%)
US region, n = 98
East	43 (43.9%)
Midwest	34 (34.7%)
West	21 (21.4%)

Abbreviation: DOAC, direct oral coagulant.